##
##
|||||Page|
|---|---|---|---|---|
|Reference and Administrative||Details ofthe Company,|its Trustees and Advisers|1-2|
|Trustees'
Report||||3-19|
|Trustees'
Responsibilities
Statement||||20|
|Independent
Auditors'|Report|on the Financial Statements||21 -24|
|Statement of Financial|Activities|||25|
|Balance Sheet||||26|
|Statement ofCash Flows||||27|
|Notes to the Financial|Statements|||28-48|
##
|REFERENCE AND|REFERENCE AND|REFERENCE AND|ADMINISTRATIVE
DETAILS|OF|OF|THE COMPANY, ITSTRUSTEES AND ADVISERS|THE COMPANY, ITSTRUSTEES AND ADVISERS|THE COMPANY, ITSTRUSTEES AND ADVISERS|THE COMPANY, ITSTRUSTEES AND ADVISERS|THE COMPANY, ITSTRUSTEES AND ADVISERS|THE COMPANY, ITSTRUSTEES AND ADVISERS|
|---|---|---|---|---|---|---|---|---|---|---|---|
||||FOR THE YEAR ENDED 31DECEMBER 2021|||||||||
|Trustees|||C Arraiano,
Chair, Working||Group on Women
in Science|||||||
||||M De La Rosa, Congress|Counsellor||||||||
||||I Diaz Moreno, Chair, Working||||Group on|the Careers||ofYoung Scientists||
||||J Dumid,
Chair, Working|Group|||on Integration|||||
||||E Fragkoulis,
Chair, Science|||and Society||Committee||||
||||L Fhsus, Chair, Network|Working Group||||(resigned|31 December 2021)|||
||||A Krol. Chair. Fellowships|Committee||||||||
||||J Buchner,
Chair, Publications||||Committee|||||
||||F Michelangeli,
Treasurer|||||||||
||||V Pakes, Secretarv General|||||||||
||||J Kos, Vice Chair, Executive|||Committee||(appointed||1 January 2021)||
||||BVhrtessy,
Chair, Advanced|||Courses Committee||||||
||||X D C Coumoul,
Chair, Network||||Working|Group (appointed|||1 January 2022)|
||||F G Sagin, Chair, Education|||Committee||||||
||||P Laidler, Chair, Executive||Committee|||||||
|Company|registered|||||||||||
|number|||08239097|||||||||
|Charity registered||||||||||||
|number|||1149638|||||||||
|Registered||office|StAndrew's
House Suite|B1||Third Floor||||||
||||59StAndrew's
Street|||||||||
||||Cambridge|||||||||
||||CB23BZ|||||||||
|Company|secretary||Professor V Paces|||||||||
|Independent||auditors|Hill Wooldridge
&Co. Limited|||||||||
||||107Hindes Road|||||||||
||||Harrow|||||||||
||||Middlesex|||||||||
||||HA1 1RU|||||||||
|Bankers||||||||||||
||||HSBC UK Bank PLC|||||||||
||||Business Banking
UK|||||||||
||||1st Floor, Sunningdale|||||||||
||||The Belfry Business Park|||||||||
||||Colonial Way|||||||||
||||Wafford|||||||||
||||WD24 4WH|||||||||
||||The Royal Bank of Scotland|||||||||
||||171Tottenham
Court Road|||||||||
||||London|||||||||
||||W1P ODL|||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|
iochemistry
and molecular
biology and relat|ed disc|iplines|iplines||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Achievements||Comments|||||||||
|FEBSAdvanced Courses|||||||||||
|29 FEBS-supported
events were planned
for 2021:due||In 2021,|FEBS continued|||to fund several|||||
|to the COVID-19 pandemic,
only 3events were able|to|Advanced||Courses with|high scientific|||content|||
|take place in person (1 Practical Course,
1 Advanced||and also|funded
YTF grants|||to allow|participation||||
|Lecture Course and
1 Workshop)
and 2joint FEBS-||ofyoung|researchers
at the|||FESS courses.|||||
|EMBO Lecture Courses,
1 Practical and Lecture Course|||||||||||
|and
1 Workshop
were held as virtual events during 2021.|||||||||||
|20 events were postponed
to 2022 (7Advanced
Lecture|||||||||||
|Courses, 5joint FEBS-EMBO Lecture Courses, 2|||||||||||
|Practical Courses, 2 Practical and Lecture Courses and 4|||||||||||
|Workshops)
and 2 Advanced
Lecture Courses to 2023.|||||||||||
|The assessment
procedure
for course selection and|||||||||||
|funding
was refined. The online database
for applications|||||||||||
|and reporting
enhanced,
FEBS-owned and branded|||||||||||
|course websites
introduced
and
collaborations
with|||||||||||
|EMBO and IUBMB continued.|||||||||||
|FEBS3+Meetings
Cesk6 Budhjovic, Czech Republic 29~ August to 1"||Support for scientists
in|||Czech Republic,||||Austria,||
|September 2021:the XXVI Annual
Congress meeting||Germany|and Slovakia;||enhanced
links||||between||
|hosted
by CSBMB(Czech Republic),
in conjunction|with|these FEBSConstituent|||Societies.||See||'Support||
|the member societies ofSlovakia, Germany
and Austria,||for Constituent
Society events' section||||||for more|||
|and with 264 participants.||details.|||||||||
|Each meeting
received support comprising 610,000tothe|||||||||||
|host society for general
meeting
organisation
and|||||||||||
|610,000 to support the attendance
of young scientists|||||||||||
|from the two other participating
societies.|||||||||||
|20th Young Scientists Forum (YSF)and 45th FEBS|||||||||||
|Congress:|||||||||||
|The 20th YSFwas due to be held
in Lovran, Croatia|in|The YSF|includes over||100PhD students||||and||
|July 2020 but, due to the COVID-19 pandemic
was first||young postdocs, whose|||attendance||at|this and|||
|postponed
to 2021 and then held as a virtual event
in||the Congress
is funded|||by|FEBSYSFawards.||||In|
|June 2021, with the same accepted participants
and|the|addition,|FEBSsupports||participation|||of|a large||
|same scientific programme.||number
of||young scientists||in its annual|||||
|||Congress|through
the FEBSBursaries|||||scheme.|||
|The 45th Congress was due to be held
in Ljubljana,|||||||||||
|Slovenia
in July 2020 but, due to the COVID-19||The annual||FEBSCongress
provides||||a platform|||
|pandemic
was first postponed
to 2021 and then held|as a|for international
scientific exchange|||||and||||
|virtual event
in July 2021, featuring
the same scientific||showcases||the newest developments||||in|||
|programme.||biochemistry,
molecular|||biology and||related||||
|||areas. The||Congress comprises
plenary|||||lectures,||
|||symposia,||poster sessions,||workshops||and other|||
|||activities|on related topics.|||The Congress|||is held||
|||in countries||with a Constituent
Socie||||ofFEBS.|||
##
##
##
|cular
biologists and scientists working
in rel
r countries ofConstituent
Societies|a|ted dis|ciplines
g|enerall|y
|and|espec|ial|ly
in|Europ|e an|
|---|---|---|---|---|---|---|---|---|---|---|---|
|Achievements|||Comments|||||||||
|FEBSCongress, Advanced Courses and Education||||||||||||
|Workshops||||||||||||
|See above|||See above|||||||||
|Lecturers for Constituent
Society and other scientific||||||||||||
|meetings||||||||||||
|National
Lectures in Turkey (held
in October 2021),The|||Effective enhancement|||of|regional,||national|and||
|Netherlands
(held in July 2021 having been postponed||from|international|meetings||by funding||of|distinguished|||
|2020) and Poland (postponed
from 2020 and subsequently|||speakers.|||||||||
|cancelled
.||||||||||||
|Other meeting sponsorship||||||||||||
|In 2021:RAFV XXXIII Argentinian
meeting (postponed|from||Eminent speakers||for|special events|||and meetings|||
|2020) and the Gordon Research Conference
USA (postponed|||beyond
Europe, which|||also allowed|||collaboration||with|
|to 2022).|||international|organisations|||and yielded FEBSjournals'|||||
||||romotion.|||||||||
|FEBSFellowships||||||||||||
|Fellows move to work in host lab in different country (see|||Promotion|ofexchange||of|skills/knowledge.|||||
|Objective 3 below).||||||||||||
|WGI schemes||||||||||||
|Support for communities
ofmolecular
life scientists
in|||Contributes|to developing/maintaining|||||pool|ofeffective||
|European
countries
with economic challenges
and/or
no
existing or active biochemical
society through
visits, the|||researchers|in Europe.||||||||
|Congress
'Sprinzl Scheme',
Education Workshops
and||CDS||||||||||
|Fellowships
as well as encouraging
the establishment||of new||||||||||
|societies and for them to benefit from FEBS.||||||||||||
##
##
|ctive 3: fa
wships|ctive 3: fa
wships|cilitating|and
s|uppo|rting|the training|of young
scienti|sts|in resea||rch,
in t|he form|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Achievements|||||||Comments||||||
|Short-Term|Fellowships||||||||||||
|16Short-Term||and 10|Summer|Fellowships||taken up.|Enhances research||possibilities||for young|scientists;|
||||||||numbers
awarded|in|accordance||with bud|eta
limits.|
|Long —Term||Fellowships|||||||||||
|6 Long-Term||awarded|(such Fellows||in post).||Very competitive|-only the most|||outstanding|scientists|
||||||||successful;
numbers||awarded|in accordance
with|||
||||||||budgetary
limits.|Accounts for major
part ofFEBS|||||
||||||||ex enditure.||||||
|Fellows Meeting|||||||||||||
|(postponed|from 2020||and held|in Vimeiro,||Portugal 2022)|Participants
are invited to participate.
No selection||||||
||||||||procedure
applies|as only current|||and past|FEBS|
||||||||Long- Term Fellows||are eligible.||The organisation||
||||||||costs are shared|with the YSF.|||||
##
##
##
|hemistry
and molecular
biology and|related disciplin|es|||
|---|---|---|---|---|
|Achievements||Comments|||
|In 2021, the FEBSPress journals
published|a similar number|Strong performance|ofFEBS' journals|in a challenging|
|ofarticles compared
to2020.59%ofall articles published||scientific publishing|environment.||
|were open access (gold OA). Journal
Impact|factors||||
|increased
for three out ofthe four journals.|||||
##
##
##
##
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
#
##
##
##
##
||||Unrestricted|Total|Total|
|---|---|---|---|---|---|
||||funds|funds|funds|
||||2021|2021|2020|
|||Note||||
|INCOME FROM:||||||
|Donations
and legacies|||8,044|8,044|8,591|
|Charitable
activities|||7,156,235|7,156,235|7,136,243|
|investments|||749,092|749,092|827,670|
|Other income|||12,260|12,260|15,356|
|TOTAL INCOME|||7,925,631|7,925,631|7,987,860|
|EXPENDITURE ON:||||||
|Raising funds||7|462,734|462,734|490,706|
|Charitable
activities||8|3,243,527|3,243,527|1,814,746|
|TOTAL EXPENDITURE|||3,706,261|3,706,261|2,305,452|
|NET INCOME BEFORE NET GAINS ON||||||
|INVESTMENTS|||4,219,370|4,219,370|5,682,408|
|Net gains on investments||13|12,241,697|12,241,697|3,278,883|
|NET MOVEMENT|IN FUNDS||16,461,067|16,461,067|8,961,291|
|RECONCILIATION|OF FUNDS:|||||
|Total funds brought|forward|17|82,717,632|82,717,632|73,756,341|
|Net movement
in funds||17|16,461,067|16,461,067|8,961,291|
|TOTAL FUNDS CARRIED FORWARD||17|99,178,699|99,178,699|82,717,632|
##
|||BALANCE SHEET|BALANCE SHEET||||
|---|---|---|---|---|---|---|
|||AS AT 31 DECEMBER 2'021|||||
|||||2021||2020|
|||Note|||||
|FIXEDASSETS|||||||
|Tangible assets||12||76,368||91,253|
|Investments||13||92,034,956||77,266,553|
|Social investments||14||72,129|||
|||||92,183,453||77,357,806|
|CURRENT ASSETS|||||||
|Debtors||15|436,652||554,894||
|Cash at bank and|in hand||7,130,070||5,254,028||
||||7,566,722||5,808,922||
|Creditors: amounts|falling due within one||||||
|year||16|(571,476)||(449,096)||
|NET CURRENT ASSETS||||6,995,246||5,359,82S|
|TOTAL ASSETSLESSCURRENT|||||||
|LIABILITIES||||99,178,699||82,717,632|
|TOTAL NET ASSETS||||99,178,699||82,717,632|
|CHARITY FUNDS|||||||
|Unrestricted
funds||17||99,178,699||82,717,632|
|TOTAL FUNDS||||99',178,699||82,717,632|
##
##
||||||2021|2020|
|---|---|---|---|---|---|---|
|||||Note|||
|CASH FLOWS FROM OPERATING ACTIVITIES|||||||
|Net cash from operating
activities||||19|3,725,785|4,434,669|
|CASH FLOWS FROM INVESTING ACTIVITIES|||||||
|Purchase oftangible
fixed assets||||||(14,318)|
|Purchase offixed asset investments|||||(63,467,550)|(32,030,400)|
|Sale offixed asset investments|||||60,940,844|26,092,998|
|Interest received|||||144,227|317,201|
|Dividends
received|||||604,865|510,469|
|Purchase of social investments|||||(72,129)||
|NET CASH USED IN INVESTING ACTIVITIES|||||(1,849,743)|(5,124,050)|
|CHANGE
IN CASH AND CASH EQUIVALENTS||IN THE|YEAR||1,876,042|(689,381)|
|Cash and cash equivalents
at the beginning|ofthe year||||5,254,028|5,943,409|
|CASH AND CASH EQUIVALENTS AT THE|END|OF THE YEAR||20|7,130,070|5,254,028|
|The notes on pages 28 to48 form part ofthese financial|||statements||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Unrestricted|Total|
|---|---|---|---|
|||funds|funds|
|||2021|2021|
|Subscriptions|receivable|8,044|8,044|
|TOTAL 2021||8,044|8,044|
|||Unrestricted|Total|
|||funds|funds|
|||2020|2020|
|Subscriptions|receivable|8,591|8,591|
|TOTAL 2020||8,591|8,591|
##
||Unrestricted|Total|
|---|---|---|
||funds|funds|
||2021|2021|
|Royalties receivable|7,156,235|7,156,235|
|TOTAL 2021|7,156,235|7,156,235|
||Unrestricted|Total|
||funds|funds|
||2020|2020|
|Royalties receivable|7,136,243|7,136,243|
|TOTAL 2020|7,136,243|7,136,243|
##
##
##
|||||Unrestricted|Total|
|---|---|---|---|---|---|
|||||funds|funds|
|||||2021|2021|
|Franked|investment|income|- dividends|604,865|604,865|
|Interest|received|||144,227|144,227|
|TOTAL|2021|||749,092|749,092|
|||||Unrestricted|Total|
|||||funds|funds|
|||||2020|2020|
|Franked|investment|income|—dividends|510,469|510,469|
|Interest|received|||317,201|317,201|
|TOTAL|2020|||827,670|827,670|
##
||Unrestricted|Total|
|---|---|---|
||funds|funds|
||2021|2021|
|Other income|12,260|12,260|
|TOTAL 2021|12,260|12,260|
##
##
|Unrestricted|Total|
|---|---|
|funds|funds|
|2020|2020|
|15,356|15,356|
##
|||Unrestricted|Total|
|---|---|---|---|
|||funds|funds|
|||2021|2021|
|Portfolio|management|462,734|462,734|
|TOTAL|2021|462,734|462,734|
|||Unrestricted|Total|
|---|---|---|---|
|||funds|funds|
|||2020|2020|
|Portfolio|management|490,706|490,706|
|TOTAL|2020|490,706|490,706|
##
##
##
||||Grant|||
|---|---|---|---|---|---|
|||Activities|funding
of|Support and||
|||undertaken|activities|governance|Total|
|||directly|(note 9)|costs|funds|
|||2021|2021|2021|2021|
|Journals||302,688||1,129,023|1,431,711|
|Congress||110,646|196,798|132,877|440,321|
|Fellowships|||816,832|74,963|891,795|
|Advanced|courses||97,132|106,860|203,992|
|Other||9,671|34,653|231,384|275,708|
|TOTAL 2021||423,005|1,145,415|1,675,107|3,243,527|
||||Grant|||
|---|---|---|---|---|---|
|||Activities|funding
ot|Supportand||
|||undertaken|activities|governance|Total|
|||directly|(note 9)|costs|funds|
|||2020|2020|2020|2020|
|Journals||299,055||505,814|804,869|
|Congress||3,162|1,390|65,197|69,749|
|Fellowships|||681,320|40,843|722,163|
|Advanced|courses||85,559|62,305|147,864|
|Other||14,766|34,539|20,796|70,101|
|TOTAL 2020||316,983|802,808|694,955|1,814,746|
##
##
##
##
||||||Total|
|---|---|---|---|---|---|
|||Journals|Congress|Other|funds|
|||2021|2021|2021|2021|
|Editorial fees and expenses||302,688|||302,688|
|Women
in Science events|||10,014||10,014|
|Education
committee events||||1,500|1,500|
|Science and Society events||||2,250|2,250|
|National
lecture|expenses|||443|443|
|FEBScongress|||67,085||67,085|
|FEBSYoung Scientist forum congress|||30,422||30,422|
|WGI participation|events|||5,478|5,478|
|Spinzl scheme|||3,125||3,125|
|TOTAL 2021||302,688|110,646|9,671|423,005|
||||||Total|
|||Journals|Congress|Other|funds|
|||2020|2020|2020|2020|
|Editorial fees and expenses||299,055|||299,055|
|Education
committee events||||14,219|14,219|
|Other education|workshops||2,195||2,195|
|FEBScongress|||354||354|
|FEBSYoung Scientist forum congress|||613||613|
|WGI participation|events||||547|
|TOTAL 2020||299,055|3,162|14,766|316,983|
##
##
##
##
||||||Advanced|
|---|---|---|---|---|---|
|||Journals|Congress|Fellowships|courses|
|||2021|2021|2021|2021|
|Journals|support costs|1,014,768||||
|HR and|communications|7,324|56,762|7,323|12,816|
|Finance||38,438|38,438|14,643|32,947|
|Governance||23,849|23,849|11,924|11,924|
|Committee costs||||34,159|42,259|
|Other support costs||16,333|8,166|4,083|4,083|
|Foreign|exchange gains|28,311|5,662|2,831|2,831|
|TOTAL|2021|1,129,023|132,877|74,963|106,860|
||||Total|
|---|---|---|---|
|||Other|funds|
|||2021|2021|
|Journals|support costs||1,014,768|
|HR and|communications|98,877|183,102|
|Finance||58,572|183,038|
|Governance||7,950|79,496|
|Committee costs|||76,418|
|Other support costs||48,998|81,663|
|Foreign|exchange losses|16,987|56,622|
|TOTAL|2021|231,384|1,675,107|
##
##
##
##
||||||Advanced|
|---|---|---|---|---|---|
|||Jouma/s|Congress|Fellowships|courses|
|||2020|2020|2020|2020|
|Journals|support costs|944,095||||
|HR and|communications|43,542|43,542|21,770|21,770|
|Finance||64,659|32,330|24,248|24,248|
|IT||55|55|54|54|
|Governance||22,094|22,094|11,047|11,047|
|Committee costs||||18,100|39,562|
|Other support costs||6,208|3,104|1,552|1,552|
|Foreign|exchange losses|(574,839)|(35,928)|(35,928)|(35,928)|
|TOTAL|2020|505,814|65,197|40,843|62,305|
||||||Total|
|||||Other|funds|
|||||2020|2020|
|Journals|support costs||||944,095|
|.HR and|communications|||14,516|145,140|
|Finance||||16,165|161,650|
|||||54|272|
|Governance||||7,366|73,648|
|Committee
costs|||||57,662|
|Other support costs||||18,623|31,039|
|Foreign|exchange losses|||(35,928)|(718,551)|
|TOTAL|2020|||20,796|694,955|
##
##
##
|||Grants to|Grants to|Total|
|---|---|---|---|---|
|||Institutions|Individuals|funds|
|||2021|2021|2021|
|Congress||146,125|50,673|196,798|
|Fellowships|||816,832|816,832|
|Advanced|courses|87,113|10,019|97,132|
|Other||25,000|9,653|34,653|
|TOTAL 2021||258,238|887,177|1,145,415|
|||Grants to|Grants to|Total|
|---|---|---|---|---|
|||Institutions|Individuals|funds|
|||2020|2020|2020|
|||6|||
|Congress|||1,390|1,390|
|Fellowships|||681,320|681,320|
|Advanced|courses|75,935|9,624|85,559|
|Other||30,000|4,539|34,539|
|TOTAL 2020||105,935|696,873|802,808|
|The Company
has|made the following
material grants to institutions|during the year:||
|---|---|---|---|
|||2021|2020|
|Advanced
courses||87,113|75,935|
|FEBSCongress Grant||146,125||
|Grants/sponsorship|to other organisations/conferences||5,000|
|FEBS3+Grant||20,000|20,000|
|Alliance for Biomedical Research Grant||5,000|5,000|
|||258,238|105,935|
##
##
##
||2021|2020|
|---|---|---|
|Wages and salaries|537,644|469,865|
|Social security costs|55,183|47,657|
|Other pension costs|79,817|69,858|
||672,644|587,380|
|Publications|(Cambridge,|UK)|
|---|---|---|
|Publications|(Heidelberg,|Germany)|
|Publications|(Barcelona,|Spain)|
|Treasury|||
|Central
admin|||
|2021|2020|
|---|---|
|18|16|
##
##
||FOR THE YEAR ENDED 31 DE|CEMBER 2021||
|---|---|---|---|
|||2021|2020|
|M De I a Rosa (Editorial services)||25,216|25,416|
|I Diaz Moreno (Editorial services)||985|650|
|C Arraiano|(Editorial services)||75|
|BVertessy|(Editorial services)|385|25|
|||26,586|26,166|
##
|||||2021|2020|
|---|---|---|---|---|---|
|Copenhagen||Journals|Administrator|20,010|44,380|
|Fellowship||Committee|Administrator|26,000|15,429|
|Advanced|Courses Committee
Administrator|||23,549|23,902|
|||||69,559|83,711|
|||||2021|2020|
|---|---|---|---|---|---|
|Copenhagen||Journals|Administrator|||
|Fellowship||Committee|Administrator|||
|Advanced|Courses Committee
Administrator|||||
##
##
##
##
##
|||Leasehold||Computer||
|---|---|---|---|---|---|
|||improvemen|Fixtures and|equipment||
|||ts|fittings|and website|Total|
||COST|||||
||At 1 January 2021|59,681|12,390|104,338|176,409|
||At 31 December 2021|59,681|12,390|104,338|176,409|
||DEPRECIATION|||||
||At 1 January 2021|7,016|2,752|75,388|85,156|
||Charge for the year|6,201|1,446|7,238|14,885|
||At 31 December 2021|13,217|4,198|82,626|100,041|
||NET BOOK VALUE|||||
||At 31 December 2021|46,464|8,192|21,712|76,368|
|.|At 31December 2020|52,665|9,638|28,950|91,253|
||FIXEDASSET INVESTMENTS|||||
||||Listed|Cash held at||
||||investments|broker|Total|
||VALUATION|||||
||At 1 January 2021||73,821,755|3,444,798|77,266,553|
||Additions||64,268,341||64,268,341|
||Disposals (proceeds 658,522,947; realised|loss 62,873,311)|(61,396,258)||(61,396,258)|
||Revaluations||15,115,008||15,115,008|
||Cash movement|||(3,218,688)|(3,218,688)|
||AT 31 DECEMBER 2021||91,808,846|226,110|92,034,956|
##
##
##
##
|14.|SOCIAL INVESTMENTS||
|---|---|---|
|||Programme|
|||related|
|||investments|
||COST||
||Additions|72,129|
|||72,129|
||IMPAIRMENT
PROVISION||
||NET BOOK VALUE||
||At 31 December 2021|72,129|
||At 31 December 2020||
||Social investments
comprise:||
||PROGRAMME
RELATED INVESTMENTS||
##
|Loans|Total|
|---|---|
|2021|2021|
|72,129|72,129|
##
|||2021|2020|
|---|---|---|---|
|Trade debtors||24,761|14,719|
|Other debtors||36,079|58,904|
|Prepayments|and accrued income|375,812|481,271|
|||436,652|554,894|
##
##
##
##
##
|STATEM|ENT OF FUNDS|- CURRENT YEAR|||||
|---|---|---|---|---|---|---|
|||||||Balance at|
|||Balance at 1||||31|
|||January|Incoming|Resources|Gains/|December|
|||2021|resources|expended|(Losses)|2021|
|UNRESTRICTED FUNDS|||||||
|General|funds|82,717,632|7,925,631|(3,706,261)|12,241,697|99,178,699|
|STATEMENT OF FUNDS - PRIOR YEAR|||||||
|||||||Balance at|
|||Balance at||||31|
|||1January|Incoming|Resources|Gains/|December|
|||2020|resources|expended|(Losses)|2020|
|||6|||||
|UNRESTRICTED FUNDS|||||||
|General|funds|73,756,341|7,987,860|(2,305,452)|3,278,883|82,717,632|
##
##
##
##
|ANALYSIS OF NET ASSETS BETWEEN FUNDS -|CURRENT YEAR||
|---|---|---|
||Unrestricted|Total|
||funds|funds|
||2021|2021|
|Tangible fixed assets|76,368|76,368|
|Fixed asset investments|92,034,956|92,034,956|
|Social investments|72,129|72,129|
|Current assets|7,566,722|7,566,722|
|Creditors due within one year|(571,476)|(571,476)|
|TOTAL|99,178,699|99,178,699|
##
|ANALYSIS OF NET ASSETS BETWEEN FUNDS - P|RIOR YEAR||
|---|---|---|
||Unrestricted|Total|
||funds|funds|
||2020|2020|
|Tangible fixed assets|91,253|91,253|
|Fixed asset investments|77,266,553|77,266,553|
|Current assets|5,808,922|5,808,922|
|Creditors due within one year|(449,096)|(449,096)|
|TOTAL|82,717,632|82,717,632|
##
##
##
||RECONCILIATION|OF NET MOVEMENT|OF NET MOVEMENT|OF NET MOVEMENT|IN FUNDS TO NET CASH FLOW|FROM OPERATING|FROM OPERATING|
|---|---|---|---|---|---|---|---|
|19.|ACTIVITIES|||||||
|||||||2021|2020|
||Net income for the|year (as||per Statement|of Financial Activities)|16,461,067|8,961,291|
||ADJUSTMENTS FOR:|||||||
||Depreciation
charges|||||14,885,|16,571|
||(Gains)/losses
on|investments||||(12,241,697)|(3,278,883)|
||Interest received|||||(144,227)|(317,201)|
||Dividends
received|||||(604,865)|(510,469)|
||(Increase)/decrease||in debtors|||118,242|(316,050)|
||Increase/(decrease)||in creditors|||122,380|(120,590)|
||NET CASH PROVIDED BYOPERATING ACTIVITIES|||||3,725,785|4,434,669|
|20.|ANALYSIS OF CASH AND|||CASH EQUIVALENTS||||
|||||||2021|2020|
||Cash
in hand|||||7,130,070|5,254,028|
||TOTAL CASH AND||CASH|EQUIVALENTS||7,130,070|5,254,028|
|21.|ANALYSIS OF CHANGES|||IN NET DEBT||||
||||||At 1||At 31|
||||||January||December|
||||||2021|Cash flows|2021|
||Cash at bank and|in|hand||5,254,028|1,876,042|7,130,070|
||||||5,254,028|1,876,042|7,130,070|
##
##
##
|non-cancell|able|operating
leases as follows:|||
|---|---|---|---|---|
||||2021|2020|
|Not later than||1 year|58,967|54,779|
|Later than|1 year and not later than 5years||73,709|123,253|
||||132,676|178,032|
##